Peripheral Artery Disease

USMLE Step 1 trap: Misses falsely elevated ABI in diabetics with calcified vessels as a PAD diagnostic pitfall. A falsely elevated ABI (>1.4) can occur in diabetics and patients with chronic kidney disease due to medial calcification causing non-compressible vessels, and toe-brachial index should be used in these patients.

Peripheral artery disease is atherosclerotic occlusion of the arteries supplying the limbs — almost always the lower extremities, and it is tested on USMLE Step 1 from ABI interpretation to cilostazol pharmacology. Students consistently trust an ABI greater than 1.4 as normal in diabetics, but medial arterial calcification makes the vessels non-compressible so the cuff reading is falsely elevated — the correct next step is a toe-brachial index, which is not affected by calcification. What changes from other atherosclerotic disease is the anatomy and clinical syndrome. This is a medium-yield topic, but the vignette traps here are reliable and repeatable.

The tricky part of PAD on Step 1 isn't the classic presentation — it's the edge cases. Most students know that claudication means exertional leg pain that resolves with rest. What they miss is Leriche syndrome, which is aortoiliac occlusion presenting with buttock and thigh pain plus absent femoral pulses plus erectile dysfunction. That triad is the exam's favorite way to test this. The other trap is the ABI: students learn that ABI less than 0.9 confirms PAD, but they forget that an ABI greater than 1.4 is also abnormal — and actually misleading — in diabetics with calcified, non-compressible vessels.

The management side is tested through cilostazol, a PDE-3 inhibitor that improves claudication symptoms but carries an absolute contraindication in heart failure. USMLE Step 1 loves contraindications — especially when the drug sounds like it should help. A patient with PAD and reduced ejection fraction is exactly the setup you'll see. Know the contraindication cold, know why it exists mechanistically, and you'll avoid the trap.

From real student decks

76%have cards covering this topic

54%have mature cards

Common misconceptions

Common mistake

Wrong: A normal ABI rules out PAD in all patients.

Right: A falsely elevated ABI (>1.4) can occur in diabetics and patients with chronic kidney disease due to medial calcification causing non-compressible vessels, and toe-brachial index should be used in these patients.

A normal ABI (0.9–1.4) does not rule out PAD in every patient. In diabetics and those with chronic kidney disease, medial arterial calcification makes vessels stiff and non-compressible, so the cuff pressure required to occlude the artery is artificially high — the ABI comes back greater than 1.4, falsely suggesting normal or supranormal perfusion. When you see this pattern in a diabetic with leg symptoms, don't trust the ABI — order a toe-brachial index instead, since digital vessels are typically spared from medial calcification.

Common mistake

Gap: Misses the classic triad of Leriche syndrome from aortoiliac occlusive disease

Leriche syndrome results from aortoiliac occlusion and classically presents with the triad of bilateral hip/buttock claudication, absent femoral pulses, and erectile dysfunction in men.

Leriche syndrome is the specific clinical picture of aortoiliac occlusion, not just generic lower extremity PAD. The atherosclerotic occlusion occurs at the aortic bifurcation or common iliac arteries, which means both legs and the internal iliac (pudendal) circulation are compromised simultaneously. This produces the triad: bilateral hip and buttock claudication (not calf claudication, which comes from femoral disease), absent or severely diminished femoral pulses bilaterally, and erectile dysfunction from pelvic ischemia. If you see a vignette with absent femoral pulses, that's your signal — the lesion is proximal.

Common mistake

Wrong: Cilostazol can be used in any PAD patient with claudication to improve walking distance.

Right: Cilostazol is contraindicated in patients with heart failure of any severity because it is a phosphodiesterase-3 inhibitor and increases mortality in this population.

Cilostazol inhibits phosphodiesterase-3, which increases cAMP in platelets and vascular smooth muscle — that's how it reduces claudication. But PDE-3 inhibition in the myocardium also has positive inotropic and chronotropic effects, and in patients with heart failure, this mechanism increases mortality, just as other inotropes do in chronic HF. This is an absolute contraindication regardless of HF severity. When a Step 1 vignette offers cilostazol as a PAD treatment option, check whether the patient has heart failure before selecting it.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Interpret an ankle-brachial index value correctly, including recognizing that an ABI greater than 1.4 is falsely elevated in diabetics and CKD patients due to vessel calcification, and knowing that toe-brachial index is the appropriate alternative in these patients.
Identify the classic triad of Leriche syndrome — bilateral hip and buttock claudication, absent femoral pulses, and erectile dysfunction — as the presentation of aortoiliac occlusive disease rather than more distal PAD.
Select appropriate PAD management including cardiovascular risk factor modification, antiplatelet therapy, supervised exercise, and cilostazol for claudication — while recognizing that cilostazol is absolutely contraindicated in any patient with heart failure.

Can you avoid these mistakes?

A 62-year-old man with type 2 diabetes and CKD presents with bilateral calf pain on exertion. His ABI is 1.5 bilaterally. What does this value indicate, and what is the next best diagnostic step?

A 58-year-old man presents with pain in his buttocks and thighs when walking, absent femoral pulses bilaterally, and inability to achieve erection. What is the diagnosis, what is the anatomical level of occlusion, and what would you expect to find on physical exam of the calves?

A 67-year-old woman with PAD and an ejection fraction of 35% has debilitating claudication limiting her to one block of walking. Her physician considers cilostazol. Is this appropriate? What is the mechanism behind your answer?

Rank the following ABI values from most to least concerning for arterial disease: 0.55, 1.10, 1.50, 0.85 — and explain what each range represents clinically.

Peripheral Artery Disease

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics